Successful desensitization for cytarabine-induced anaphylaxis: The first documented case report in Vietnam
Hiep Le Van, Thong Pham Huy, Minh Nguyen Anh, Truong Nguyen Huu, Mui Tran Thi
Hanoi Medical University Bạch Mai Hospital Hanoi Medical University Hospital
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
The chemotherapeutic agent cytarabine is an uncommon cause of anaphylaxis. According to the World Allergy Organization, the diagnosis of anaphylaxis is primarily based on clinical symptoms, while biomarkers play a supporting role. However, in some cases, the underlying factors are complex and challenging to identify, especially in countries that lack the laboratory capacity to perform specialized tests. Drug desensitization – the temporary induction of tolerance to a sensitized drug – is the optimal approach when no alternative drug is available; however, desensitization is not always successful. Adjusting the desensitization protocol by extending the duration of each step or intensifying premedication drugs is the proposed solution to address this problem. To date, there have been few reports about cytarabine desensitization. We report the case of a 31-year-old male with acute myeloid leukemia (AML-M2) who developed severe anaphylaxis during his fourth course of high-dose cytarabine. An initial 13-step desensitization protocol failed at step 12. Consequently, a revised protocol was implemented, featuring intensified anaphylaxis premedication – including hydrocortisone, montelukast, and levocetirizine administered 3 days before and during the procedure. This modified approach successfully induced temporary tolerance, allowing the patient to complete the required 3,000 mg/day dose without further adverse reactions. This is the first reported case of successful cytarabine desensitization following anaphylaxis in Vietnam. Our findings highlight that anaphylaxis premedication is essential for the success of rapid desensitization protocols, especially in high-risk patients or after initial failure.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Drug-Induced Adverse Reactions
Food Allergy and Anaphylaxis Research · Pharmacovigilance and Adverse Drug Reactions